期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
The predictive value of vascular endothelial growth factor and Ki-67 expression on neoadjuvant therapy in rectal cancer 被引量:1
1
作者 Shumei Jiang RenbenWang +3 位作者 Jinming Yu Zhenjiang Zhang Dianbin Mu Zhongfa Xu 《The Chinese-German Journal of Clinical Oncology》 CAS 2009年第1期16-20,共5页
Objective: To investigate the expressions of vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (Ki-67) in patients with rectal adenocarcinoma and their associations with neoadjuvant... Objective: To investigate the expressions of vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (Ki-67) in patients with rectal adenocarcinoma and their associations with neoadjuvant therapy. Methods: The expressions of Ki-67 and VEGF in 32 cases of rectal adenocarcinoma, including both pretreatment tumor biopsies and postoperative specimen, were detected by immunohistochemistry using specific antibodies, and were correlated with clinicopathological factors. Results: The intensity of VEGF staining was significantly correlated with lymph nodal metastasis (P =0.033), depth of tumor invasion (P =0.007) and tumor stage (P= 0.016), but not with histological types, tumor sizes, patients' ages and genders (P 〉 0.05). Low level of VEGF expression had significant correlation with the high sensitivity of response to neoadjuvant therapy (P = 0.016). The transient increase of VEGF expression could be seen after neoadjuvant therapy (P = 0.035). Ki-67 labeling index (Ki-67-LI) was significantly correlated with lymph node metastasis (P = 0.028), but not correlated to tumor sizes, patients' ages and genders (P 〉 0.05). Tumors with lower Ki-67-LI were more sensitive to neoadjuvant therapy (P = 0.032). The Ki-67 level decreased after neoadjuvant therapy, but no statistical significance was found (P 〉 0.05). Conclusion: Our results demonstrate that the expression of VEGF and Ki-67 in pretreatment rectal adenocarcinoma biopsies may be predictive of tumor response to neoadjuvant therapy. 展开更多
关键词 rectal neoplasms ADENOCARCINOMA vascular endothelial growth factor (vegf proliferating cell nuclear antigen ki-67
下载PDF
The expressions and clinical significance of P53, C-erbB-2 and VEGF in non-small cell lung cancer
2
作者 Aiqin Gu Yu Xin +3 位作者 Gang Chen Baohui Han Hao Ji Bo Yan 《The Chinese-German Journal of Clinical Oncology》 CAS 2008年第2期78-80,共3页
Objective: To investigate the expressions and the clinical significance of P53, C-erbB-2 and vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC). Methods: 121 specimens of NSCLC were ... Objective: To investigate the expressions and the clinical significance of P53, C-erbB-2 and vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC). Methods: 121 specimens of NSCLC were examined for P53, C-erbB-2 and VEGF by immunohistochemical staining. Results: The positive rates of P53, C-erbB-2 and VEGF in the carcinomatous tissue were 43%, 39% and 31% respectively. P53 gene protein expression in lung cancer was significantly related to histological type and P-TNM staging of lung cancer patients (P 〈 0.05), and was not associated with the sex, age, the size of primary cancer, lymph node metastasis and cell differentiation (P 〉 0.05). C-erbB-2 gene protein expression in lung cancer was closely related to histological type and cell differentiation (P 〈 0.05), and was not associated with the sex, age, the size of primary cancer, lymph node metastasis and P-TNM staging of lung cancer patients (P 〉 0.05). VEGF in lung cancer was only closely related to cell differentiation (P 〈 0.05), and was not associated with the sex, age, the size of pdmary cancer, lymph node metastasis, histological type and P-TNM staging of lung cancer patients (P 〉 0.05). Conclusion: It is possible for P53, C-erbB-2 and VEGF to play an important role in the oncogenesis and development of non-small cell lung cancer. 展开更多
关键词 non-small cell lung cancer (NSCLC) p53 C-ERBB-2 vascular endothelial growth factor (vegf
下载PDF
Effects of Buyang Huanwu Tang Combined with Bone Marrow Mesenchymal Stem Cell Transplantation on the Expression of VEGF and Ki-67 in the Brain Tissue of the Cerebral Ischemia-Reperfusion Model Rat 被引量:30
3
作者 张运克 韩雪永 车志英 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2010年第4期278-282,共5页
Objective:To explore the mechanism of Buyang Huanwu Tang (补阳还五汤 Decoction Invigorating Yang for Recuperation) combined with bone marrow mesenchymal stem cells (MSCs) transplantation in protecting nerves of cerebr... Objective:To explore the mechanism of Buyang Huanwu Tang (补阳还五汤 Decoction Invigorating Yang for Recuperation) combined with bone marrow mesenchymal stem cells (MSCs) transplantation in protecting nerves of cerebral ischemic injury. Methods: Local cerebral ischemia-reperfusion rat model was established with modified Zea-Longa thread-occlusion method, and MSCs were injected into the caudal vein, and Buyang Huanwu Tang(补阳还五汤)was administrated. Vascular endothelial growth factor (VEGF) and Ki-67 expression in the ischemic side of the brain in the cerebral ischemic-reperfusion rat were detected with immuno-histochemical staining method. Results: VEGF and Ki-67 expressions were significantly up-regulated in the MSCs group and the combination group, with significant differences as compared with the model group and the sham operation group (P<0.05), and with the most strongest effect in the combination group. Conclusion: Buyang Huanwu Tang(补阳还五汤)combined with MSCs transplantation repairs the injured blood vessels and lesion tissues possibly by up-regulation of VEGF and Ki-67 expression. 展开更多
关键词 Buyang Huanwu Tang marrow mesenchymal stem cell cerebral ischemia-reperfusion immunohistochemical method vascular endothelial growth factor (vegf and ki-67
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部